SNDL Inc

Aktienanalyse zu SNDL Inc (SNDL)

$1.360

-0.010 (-0.73%)Zum Schluss

Loading chart…
High
1.380
Open
1.350
VWAP
1.36
Vol
1.06M
Mkt Cap
507.43M
Low
1.345
Amount
1.44M
EV/EBITDA, TTM
9.28

SNDL Inc., through its wholly owned subsidiaries, is a vertically integrated cannabis company and a private-sector liquor and cannabis retailer in Canada. Its retail banners include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds and Spiritleaf. With products available in licensed cannabis retail locations nationally, its consumer-facing cannabis brands include Top Leaf, Contraband, Palmetto, Bon Jak, La Plogue, Versus, Value Buds, Grasslands, Vacay, Pearls by Gron, No Future and Bhang Chocolate. Its liquor retail segment includes the sales of wines, beers and spirits. Its cannabis retail segment includes the sales of cannabis products and accessories through corporate-owned and franchised cannabis retail operations. Its cannabis operations segment operates as a licensed producer that grows cannabis using indoor facilities and manufactures cannabis products, providing cannabis processing services. Its investments segment includes deployment of capital to investment opportunities.

www.sndl.com

AI analysis of SNDL Inc (SNDL)

hold

SNDL Inc is currently trading at $1.355, which is significantly below the analyst price target of $3.50, suggesting potential upside. However, the stock has experienced a 22.13% year-to-date decline and a 45.14% drop over the past year, indicating ongoing challenges. The RSI is at 61.943, suggesting the stock is nearing overbought territory, which could limit short-term gains. The main risk is the widening net loss of C$7.8 million in Q2 2026, which reflects deteriorating financial health.

Bewertungskennzahlen

The current forward P/E ratio for SNDL Inc (SNDL) is 212.77, compared to its 5-year average forward P/E of 13.83.

Forward P/E

Overvalued
5Y Average P/E
13.83
Current P/E
212.77
Überbewertet
139.07
Unterbewertet
-111.40

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-2.80
Current EV/EBITDA
9.28
Überbewertet
121.92
Unterbewertet
-127.53

Forward P/S

Fair
5Y Average P/S
1.31
Current P/S
0.37
Überbewertet
4.56
Unterbewertet
-1.93

Alphio AI Price Scenarios for SNDL

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%SNDL

$1.55

Szenariopreis

B

Base

Base · 50%SNDL

$1.43

Szenariopreis

B

Bear

Bear · 25%SNDL

$1.23

Szenariopreis

Whales holding SNDL

A

Armistice Capital LLC

+ HoldingSNDL

+14.71%

3M Return

Event-Zeitleiste

2026-07-28 (ET)

07:31:00

SNDL Q2 Results Show Market Softness, Expected Annual Revenue Over $1B

2026-05-27 (ET)

18:40:00

SNDL Cancels Acquisition of Ontario Retail Locations

2026-04-29 (ET)

07:00:00

SNDL CEO Anticipates Improvement in Cannabis Market in H2 2026

2026-03-12 (ET)

07:00:00

SNDL Reports Q4 Revenue of $252.5M

2025-11-21 (ET)

16:31:11

SNDL reveals continuation of share buyback initiative

News

SNDL FAQ — answered by Alphio AI

SNDL Inc., through its wholly owned subsidiaries, is a vertically integrated cannabis company and a private-sector liquor and cannabis retailer in Canada. Its retail banners include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds and Spiritleaf. With products available in licensed cannabis retail locations nationally, its consumer-facing cannabis brands include Top Leaf, Contraband, Palmetto, Bon Jak, La Plogue, Versus, Value Buds, Grasslands, Vacay, Pearls by Gron, No Future and Bhang Chocolate. Its liquor retail segment includes the sales of wines, beers and spirits. Its cannabis retail segment includes the sales of cannabis products and accessories through corporate-owned and franchised cannabis retail operations. Its cannabis operations segment operates as a licensed producer that grows cannabis using indoor facilities and manufactures cannabis products, providing cannabis processing services. Its investments segment includes deployment of capital to investment opportunities. It operates in the Healthcare sector (MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS industry).

SNDL Inc is currently trading at $1.355, which is significantly below the analyst price target of $3.50, suggesting potential upside. However, the stock has experienced a 22.13% year-to-date decline and a 45.14% drop over the past year, indicating ongoing challenges. The RSI is at 61.943, suggesting the stock is nearing overbought territory, which could limit short-term gains. The main risk is the widening net loss of C$7.8 million in Q2 2026, which reflects deteriorating financial health.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten